AKT1 and cancer: After treatment with the eccMIR-106a/363 cluster or eccMIR-374b/421 cluster, DEGs were enriched in several cancer-associated signaling pathways, including the PI3K-Akt, MAPK, and Notch pathways (Fig. 5G).